1. Home
  2. PMCB vs DLPN Comparison

PMCB vs DLPN Comparison

Compare PMCB & DLPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

HOLD

Current Price

$0.45

Market Cap

6.3M

Sector

Health Care

ML Signal

HOLD

Logo Dolphin Entertainment Inc.

DLPN

Dolphin Entertainment Inc.

HOLD

Current Price

$1.19

Market Cap

14.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMCB
DLPN
Founded
1996
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.3M
14.6M
IPO Year
2001
2008

Fundamental Metrics

Financial Performance
Metric
PMCB
DLPN
Price
$0.45
$1.19
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
87.9K
8.6K
Earning Date
03-17-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.87
EPS
N/A
N/A
Revenue
N/A
$56,699,389.00
Revenue This Year
N/A
$14.73
Revenue Next Year
N/A
$7.41
P/E Ratio
N/A
N/A
Revenue Growth
N/A
9.70
52 Week Low
$0.47
$1.02
52 Week High
$1.51
$1.88

Technical Indicators

Market Signals
Indicator
PMCB
DLPN
Relative Strength Index (RSI) 24.65 45.78
Support Level N/A $1.06
Resistance Level $0.57 $1.20
Average True Range (ATR) 0.03 0.05
MACD -0.00 -0.00
Stochastic Oscillator 9.16 16.60

Price Performance

Historical Comparison
PMCB
DLPN

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing, and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials. The company operates within the U.S.

Share on Social Networks: